Delivery Order SPE2DB20D3104-SPE2DB23FV9A7

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ceftriaxone 2 GM-D5W bags. The firm-fixed-price delivery order, valued at $1,461.92, has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,677.21 firm fixed-price contract is for the supply of Ceftriaxone 1 GM-D5W bags, a critical medical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,584.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical pharmaceutical product used in medical care. This is a Firm Fixed Price Delivery Order contract with a completion date of June 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,477.10 fixed-price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $4,165.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ceftriaxone 2 GM-D5W Bags, a critical medical product. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.11 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract has a period of performance through December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,106.00 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,046.96, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,058.95, is a Firm Fixed Price Delivery Order for the supply of CEFTRIAXONE 1 GM-D5W BAGS, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.28 firm fixed-price delivery order is for the supply of 4,567,331,582 units of ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV9A7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $7,107.14 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ceftriaxone 1 GM-D5W bags. This contract has an ultimate completion date of September 14, 2023.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This specific contract award was not designated with a set-aside requirement, indicating open competition. The contract is part of AmerisourceBergen's broader portfolio of federal contract awards, demonstrating the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 10:21 AM